116 related articles for article (PubMed ID: 30709562)
1. Optimization of a rapid test for antibodies to the Chlamydia trachomatis antigen Pgp3.
Gwyn S; Mkocha H; Randall JM; Kasubi M; Martin DL
Diagn Microbiol Infect Dis; 2019 Apr; 93(4):293-298. PubMed ID: 30709562
[TBL] [Abstract][Full Text] [Related]
2. Lateral flow-based antibody testing for Chlamydia trachomatis.
Gwyn S; Mitchell A; Dean D; Mkocha H; Handali S; Martin DL
J Immunol Methods; 2016 Aug; 435():27-31. PubMed ID: 27208400
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the reproducibility of a serological test for antibodies to Chlamydia trachomatis pgp3: A potential surveillance tool for trachoma programs.
Kaur H; Dize L; Munoz B; Gaydos C; West SK
J Microbiol Methods; 2018 Apr; 147():56-58. PubMed ID: 29501689
[TBL] [Abstract][Full Text] [Related]
4. The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma.
Gwyn S; Nute AW; Sata E; Tadesse Z; Chernet A; Haile M; Zeru T; Bethea D; Laurent C; Callahan EK; Nash SD; Martin DL
Am J Trop Med Hyg; 2021 Aug; 105(5):1362-1367. PubMed ID: 34398819
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a field test for antibodies against Chlamydia trachomatis during trachoma surveillance in Nepal.
Sun MJ; Zambrano AI; Dize L; Munoz B; Gwyn S; Mishra S; Martin DL; Sharma S; West SK
Diagn Microbiol Infect Dis; 2017 May; 88(1):3-6. PubMed ID: 28214223
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Platforms for Testing Antibody Responses against the
Gwyn S; Cooley G; Goodhew B; Kohlhoff S; Banniettis N; Wiegand R; Martin DL
Am J Trop Med Hyg; 2017 Dec; 97(6):1662-1668. PubMed ID: 29016320
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area.
West SK; Munoz B; Kaur H; Dize L; Mkocha H; Gaydos CA; Quinn TC
Sci Rep; 2018 Feb; 8(1):3520. PubMed ID: 29476106
[TBL] [Abstract][Full Text] [Related]
8. Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey.
West SK; Munoz B; Weaver J; Mrango Z; Dize L; Gaydos C; Quinn TC; Martin DL
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004352. PubMed ID: 26771906
[TBL] [Abstract][Full Text] [Related]
9. Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.
Kim JS; Oldenburg CE; Cooley G; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Keenan JD; Gaynor BD; Porco TC; Lietman TM; Martin DL
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007127. PubMed ID: 30689671
[TBL] [Abstract][Full Text] [Related]
10. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
Burr SE; Hart J; Samikwa L; Chaima D; Cooley G; Martin D; Masika M; Solomon AW; Bailey RL; Kalua K
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
[TBL] [Abstract][Full Text] [Related]
11. Serology for trachoma surveillance after cessation of mass drug administration.
Martin DL; Bid R; Sandi F; Goodhew EB; Massae PA; Lasway A; Philippin H; Makupa W; Molina S; Holland MJ; Mabey DC; Drakeley C; Lammie PJ; Solomon AW
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003555. PubMed ID: 25714363
[TBL] [Abstract][Full Text] [Related]
12. The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children.
West SK; Munoz B; Mkocha H; Gaydos CA; Quinn TC
Sci Rep; 2020 Sep; 10(1):15225. PubMed ID: 32938957
[TBL] [Abstract][Full Text] [Related]
13. Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem.
Senyonjo LG; Debrah O; Martin DL; Asante-Poku A; Migchelsen SJ; Gwyn S; deSouza DK; Solomon AW; Agyemang D; Biritwum-Kwadwo N; Marfo B; Bakajika D; Mensah EO; Aboe A; Koroma J; Addy J; Bailey R
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007027. PubMed ID: 30550537
[TBL] [Abstract][Full Text] [Related]
14. Comparison of platforms for testing antibodies to Chlamydia trachomatis antigens in the Democratic Republic of the Congo and Togo.
Gwyn S; Awoussi MS; Bakhtiari A; Bronzan RN; Crowley K; Harding-Esch EM; Kassankogno Y; Kilangalanga JN; Makangila F; Mupoyi S; Ngondi J; Ngoyi B; Palmer S; Randall JM; Seim A; Solomon AW; Stewart R; Togbey K; Uvon PA; Martin DL
Sci Rep; 2021 Mar; 11(1):7225. PubMed ID: 33790370
[TBL] [Abstract][Full Text] [Related]
15. Assessment and utility of 2 Chlamydia trachomatis Pgp3 serological assays for seroprevalence studies among women in the United States.
Danavall DC; Gwyn S; Anyalechi GE; Bowden KE; Hong J; Kirkcaldy RD; Bernstein KT; Kersh EN; Martin D; Raphael BH
Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115480. PubMed ID: 34325205
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati.
Cama A; Müller A; Taoaba R; Butcher RMR; Itibita I; Migchelsen SJ; Kiauea T; Pickering H; Willis R; Roberts CH; Bakhtiari A; Le Mesurier RT; Alexander NDE; Martin DL; Tekeraoi R; Solomon AW;
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005863. PubMed ID: 28898240
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three serological assays to measure antibody response to Chlamydia antigen Pgp3 in adolescent and young adults with pelvic inflammatory disease.
Dize L; Martin D; Gwyn S; Perin J; Gaydos C; Trent M
Int J STD AIDS; 2018 Nov; 29(13):1324-1329. PubMed ID: 30049256
[TBL] [Abstract][Full Text] [Related]
18. Validation of immunoassays for the Chlamydia trachomatis antigen Pgp3 using a chimeric monoclonal antibody.
Goodhew B; Tang X; Goldstein J; Lee J; Martin D; Gwyn S
Sci Rep; 2023 May; 13(1):7281. PubMed ID: 37142607
[TBL] [Abstract][Full Text] [Related]
19. CT694 and pgp3 as serological tools for monitoring trachoma programs.
Goodhew EB; Priest JW; Moss DM; Zhong G; Munoz B; Mkocha H; Martin DL; West SK; Gaydos C; Lammie PJ
PLoS Negl Trop Dis; 2012; 6(11):e1873. PubMed ID: 23133684
[TBL] [Abstract][Full Text] [Related]
20. Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district.
Odonkor M; Naufal F; Munoz B; Mkocha H; Kasubi M; Wolle M; West S
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009343. PubMed ID: 33861754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
